By Daniel Njienue-May 1, 2020, news/comments
BENIN CITY-With the saddled situation over the world, brought by the coronavirus 210 countries battle to save lives of its citizens. Currently, the global cases is 3,308,678, Deaths: 234,123 while recovered is 1,042,991. Nigeria cases currently is: 1,932 Deaths: 58 Recovered: 319. Worried by this uncontrollable disease, a group of Nigerian Catholic faithfuls have developed a drug for the treatment of the dreadful virus. led by Rev.Fr Anselm Adodo, the founder, Pax Herbal Clinic and Research Laboratories (PHCRL), an alternative medicine product manufacturing company in Ewu-Esan in Edo State. According to Fr. Adodo, he referred to the discovered COVID-19 drug as PaxHerbal CVD Plus, which he said is currently awaiting the approval of the National Agency for Food and Drug Administration and Control (NAFDAC).
Fr.Adodo with Governor Obaseki
It could be recalled that the Catholic priest had earlier presented the drug to Governor, Godwin Obaseki of Edo state. The Priest however noted in an official page of the clinic on Wednesday 29 of April, 2020, stressing that the drug contained herbs and active phytoconstituents with documented scientific evidence based on clinical reports of their efficacy and safety.
The research is a joint effort of experts from University of Lagos and University of Benin, a tertiary health institution—Irrua Specialist Teaching Hospital, Edo state and experts sent by Prof Tunde Salako and Prof Catherine Adeyeye. Professor Salako is the head of the National Institute of Pharmaceutical Research and Development, while Professor Adeyeye is the director-general of the National Agency for Food and Drug Administration and Control (NAFDAC).
Doctors treating covid-19 patients
Adodo noted further that plant-based drugs, whether crude or refined, seemed to be the best alternative approach to treat COVID-19.“At the moment, plant-based drugs, whether crude or refined, are seemingly the best alternative approach to the treatment of COVID-19 menace. The new generation of vaccine development for combating emergent diseases needed time because of safety profiling. On the other hand, plant-based formulations are easily manufactured, stored and distributed and are readily acceptable by the local population. Moreover, they can easily be handled by both professional and non-medical research personnel with no risk of contamination. The PHCRL has developed a novel drug, called PaxHerbal CVD Plus specifically for the treatment of COVID-19. These herbs have been used in several therapeutic formulations of Paxherbals over the past 25 years for the treatment of hepatitis C, tuberculosis, HIV/AIDS, bronchitis, pneumonia and malaria’ he concluded.
For breaking news, call +2348028592006, +2348148704264, email us: email@example.com. Follow us on twitter: @afrikanwatchm, facebook: afrikanwatch Network, afrikanwatch, www.afrikanwatchngr.com, instagram, @afrikanwatchm